Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Ipca Laboratories Ltd.
NSE: IPCALAB
|
BSE: 524494
|
ISIN: INE571A01038
|
Industry: Pharmaceuticals
|
Expensive Performer
1398.1000
-26.70
(
-1.87
%)
NSE
Jun 02, 2025
09:37 AM
32.90% Gain from 52W Low
Volume:
34,058
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Ipca Laboratories Ltd.
14 Feb 2025
1398.10
-1.87%
IPCA LABORATORIES
Accumulate:
Ipca Laboratories Ltd.
by
Prabhudas Lilladhar
Target: 1700 | Upside : 21.6%
Prabhudas Lilladhar
Number of FII/FPI investors increased from 282 to 294 in Mar 2025 qtr.
More from Ipca Laboratories Ltd.
Recommended
Market opens lower, Vodafone Idea's Q4FY25 net loss contracts 6.6% YoY to Rs 7,166.1 crore
Trendlyne Marketwatch |
02 Jun 2025, 09:21AM
Five Interesting Stocks Today - May 30, 2025
The Baseline |
30 May 2025
IPCA Labs’ domestic formulations business to drive growth
|
05 Jul 2021